Literature DB >> 23224891

Human macrophages and monocytes express functional Na(+)/Ca (2+) exchangers 1 and 3.

Rosaria I Staiano1, Francescopaolo Granata, Agnese Secondo, Angelica Petraroli, Stefania Loffredo, Lucio Annunziato, Massimo Triggiani, Gianni Marone.   

Abstract

The Na(+)/Ca(2+) exchanger (NCX) is a plasma membrane protein that can switch Na(+) and Ca(2+) in either direction to maintain the homeostasis of intracellular Ca(2+). A family of three genes (NCX1, NCX2, and NCX3) has been identified in neurons and muscle cells. NCX activity has also been reported in certain immune cells (e.g., mast cells). We have examined the expression and function of these NCX isoforms in the human monocytes and lung macrophages. Monocytes were purified from peripheral blood of healthy donors. Macrophages (HLM) were isolated and purified from the lung parenchyma of patients undergoing thoracic surgery. NCX1 and NCX3, but not NCX2, were expressed in HLM and monocytes at both mRNA and protein level. Exposure to Na(+)-free medium induced a significant increase in intracellular calcium concentration ([Ca(2+)](i)) in both cell types, suggesting that NCX isoforms expressed on these cells were functionally active. This response was completely abolished by the NCX inhibitor 5-(N-4-chlorobenzyl)-20,40-dimethylbenzamil (CB-DMB). In addition, incubation of macrophages with Na(+)-free medium induced a marked release of TNF-α. Preincubation of HLM with CB-DMB and RNAi-mediated knockdown of NCX1 blocked TNF-α release. Our results demonstrate that human macrophages and monocytes express NCX1 and NCX3 that operate in a bidirectional manner to restore [Ca(2+)](i) to generate Ca(2+) signals and to induce TNF-α production. We suggest that NCX may modulate Ca(2+) homeostasis and proinflammatory functions in human macrophages and monocytes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23224891     DOI: 10.1007/978-1-4614-4756-6_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  6 in total

1.  Beta-adducin and sodium-calcium exchanger 1 gene variants are associated with systemic lupus erythematosus and lupus nephritis.

Authors:  Giuseppe A Ramirez; Chiara Lanzani; Enrica P Bozzolo; Laura Zagato; Lorena Citterio; Nunzia Casamassima; Valentina Canti; Maria Grazia Sabbadini; Patrizia Rovere-Querini; Paolo Manunta; Angelo A Manfredi
Journal:  Rheumatol Int       Date:  2015-06-05       Impact factor: 2.631

2.  Trafficking of Na+/Ca2+ exchanger to the site of persistent inflammation in nociceptive afferents.

Authors:  Nicole N Scheff; Michael S Gold
Journal:  J Neurosci       Date:  2015-06-03       Impact factor: 6.167

3.  Sodium/calcium exchanger is upregulated by sulfide signaling, forms complex with the β1 and β3 but not β2 adrenergic receptors, and induces apoptosis.

Authors:  Jana Markova; Sona Hudecova; Andrea Soltysova; Marta Sirova; Lucia Csaderova; Lubomira Lencesova; Karol Ondrias; Olga Krizanova
Journal:  Pflugers Arch       Date:  2013-10-10       Impact factor: 3.657

4.  Cytokine/Chemokine Release Patterns and Transcriptomic Profiles of LPS/IFNγ-Activated Human Macrophages Differentiated with Heat-Killed Mycobacterium obuense, M-CSF, or GM-CSF.

Authors:  Samer Bazzi; Emale El-Darzi; Tina McDowell; Helmout Modjtahedi; Satvinder Mudan; Marcel Achkar; Charles Akle; Humam Kadara; Georges M Bahr
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 5.  Mercury promotes catecholamines which potentiate mercurial autoimmunity and vasodilation: implications for inositol 1,4,5-triphosphate 3-kinase C susceptibility in kawasaki syndrome.

Authors:  Deniz Yeter; Richard Deth; Ho-Chang Kuo
Journal:  Korean Circ J       Date:  2013-09       Impact factor: 3.243

6.  Type 1 Sodium Calcium Exchanger Forms a Complex with Carbonic Anhydrase IX and Via Reverse Mode Activity Contributes to pH Control in Hypoxic Tumors.

Authors:  Veronika Liskova; Sona Hudecova; Lubomira Lencesova; Filippo Iuliano; Marta Sirova; Karol Ondrias; Silvia Pastorekova; Olga Krizanova
Journal:  Cancers (Basel)       Date:  2019-08-09       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.